With enpatoran soon entering Phase III clinical trials, the Phase II safety and efficacy results support the drug’s development.

SYDNEY, April 1 (Reuters) - Anthropic said on Wednesday it would sign an agreement to share its economic index data with the ...

The Pick ‘n Save closures were the start of a troubling trend. Several other stores in the Milwaukee area have closed and one ...

Drug Safety Monitoring Board (DSMB) gives Noveome Biotherapeutics a recommendation to continue the Necrotizing ...

GLP-1s are linked to a broad range of adverse events — largely gastrointestinal, metabolic, and psychological — across ...

This growth in illicit activity has pushed encryption to the center of debates about national security, law enforcement and ...

Newly compiled traffic data reveals ongoing safety challenges on Las Vegas roads, with local attorney Paul Padda ...

Public safety drone programs are evolving from ad hoc flights to structured operations. Learn why systems of record now define success.

Data reveals alarming number of shootings near New Mexico schools ...

Mokaram Injury Lawyers reports that Mississippi, Arizona, and South Carolina are the most dangerous states for drivers due to ...

F1 TV strategist explains how Mercedes has built a pattern of success behind their wins across all three 2026 season races, ...

Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable Safety, Splicing and vHOT Data March ...